1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
3.8. Product Pipeline Analysis
3.9. Incidence and Prevalence Analysis
3.10. Patent Analysis
4. TECHNOLOGICAL OUTLOOK
5. POINT-OF-CARE DIAGNOSTIC DEVICES MARKET BY PRODUCT TYPE
5.1. Introduction
5.2 Glucose Monitoring Devices
5.3. Infectious Disease Testing Devices
5.4. Cardiac Marker Testing Devices
5.5. Blood Gas & Electrolyte Analysers
5.6. Pregnancy & Fertility Testing Devices
6. POINT-OF-CARE DIAGNOSTIC DEVICES MARKET BY TECHNOLOGY
6.1. Introduction
6.2. Lateral Flow Assays
6.3. Immunoassays
6.4. Molecular Diagnostics
6.5. Microfluidics
7. POINT-OF-CARE DIAGNOSTIC DEVICES MARKET BY APPLICATION
7.1. Introduction
7.2. Hospitals & Clinics
7.3. Diagnostic Laboratories
7.4. Home Care Settings
7.5. Ambulatory Care Centers
8. POINT-OF-CARE DIAGNOSTIC DEVICES MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. United Kingdom
8.4.2. Germany
8.4.3. France
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Abbott Laboratories
10.2. Roche Diagnostics
10.3. Siemens Healthineers
10.4. Thermo Fisher Scientific
10.5. Becton Dickinson and Company
10.6. QuidelOrtho Corporation
10.7. Everlywell
10.8. LetsGetChecked
10.9. OraSure Technologies
10.10. Cue Health
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations